Cargando…

Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series

BACKGROUND: Current systemic therapy for nontuberculous mycobacterial pulmonary infection is limited by poor clinical response rates, drug toxicities and side effects. The addition of aerosolized amikacin to standard oral therapy for nontuberculous mycobacterial pulmonary infection may improve treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davis, Kala K, Kao, Peter N, Jacobs, Susan S, Ruoss, Stephen J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1808062/ https://www.ncbi.nlm.nih.gov/pubmed/17319962 http://dx.doi.org/10.1186/1471-2466-7-2

Ejemplares similares

Amikacin liposome and Mycobacterium avium complex: A systematic review
por: Zangiabadian, Moein, et al.
Publicado: (2022)

Comparison of Treatment Outcomes of Cavitary Mycobacterium avium Complex Pulmonary Disease with Streptomycin or Amikacin Use
por: Kim, Seong Min, et al.
Publicado: (2023)

Outcomes of Inhaled Amikacin and Clofazimine-Containing Regimens for Treatment of Refractory Mycobacterium avium Complex Pulmonary Disease
por: Kim, Bo-Guen, et al.
Publicado: (2020)

Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease: A 12-Month Open-Label Extension Clinical Trial
por: Winthrop, Kevin L., et al.
Publicado: (2021)

Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
por: Shirley, Matt
Publicado: (2019)

Correction to: Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
por: Shirley, Matt
Publicado: (2019)

Treatment of severe Mycobacterium avium complex pulmonary disease with adjunctive amikacin and clofazimine versus standard regimen alone: a retrospective study
por: Zweijpfenning, Sanne M.H., et al.
Publicado: (2021)

Association between 16S rRNA gene mutations and susceptibility to amikacin in Mycobacterium avium Complex and Mycobacterium abscessus clinical isolates
por: Kim, Su-Young, et al.
Publicado: (2021)

Intestinal infection following aerosol challenge of calves with Mycobacterium avium subspecies paratuberculosis
por: Eisenberg, Susanne WF, et al.
Publicado: (2011)

Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use
por: Hoy, Sheridan M.
Publicado: (2021)

Amikacin liposome inhalation suspension clinical benefit–risk assessment for refractory Mycobacterium avium complex lung disease
por: Marras, Theodore K., et al.
Publicado: (2022)

805. Amikacin Liposome Inhalation Suspension (ALIS) Add-on Therapy for Refractory Mycobacterium avium Complex (MAC) Lung Disease: Effect of In Vitro Amikacin Susceptibility on Sputum Culture Conversion
por: Brown-Elliott, Barbara A, et al.
Publicado: (2018)

Correction to: Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use
por: Hoy, Sheridan M.
Publicado: (2021)

Delivery of Aerosolized Liposomal Amikacin as a Novel Approach for the Treatment of Nontuberculous Mycobacteria in an Experimental Model of Pulmonary Infection
por: Rose, Sasha J., et al.
Publicado: (2014)

Mycobacterium avium Subspecies paratuberculosis: Human Exposure through Environmental and Domestic Aerosols
por: Rhodes, Glenn, et al.
Publicado: (2014)

Pulmonary Mycobacterium avium Complex Infection Showing Extensive Consolidation
por: Yamazoe, Masami, et al.
Publicado: (2022)

A comparative study of Mycobacterium avium subsp. avium and Mycobacterium avium subsp. hominissuis in experimentally infected pigs
por: Agdestein, Angelika, et al.
Publicado: (2012)

Diagnosis and Management of Drug-Induced Interstitial Lung Disease Associated with Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium Avium Complex Pulmonary Disease: A Case Report
por: Hashimoto, Kazuki, et al.
Publicado: (2023)

Early-Phase Adverse Effects and Management of Liposomal Amikacin Inhalation for Refractory Mycobacterium avium Complex Lung Disease in Real-World Settings
por: Morita, Atsuho, et al.
Publicado: (2022)

Treatment of Mycobacterium avium Complex Pulmonary Disease
por: Kwon, Yong-Soo, et al.
Publicado: (2019)

Amikacin Liposomal Inhalation Suspension in the Treatment of Mycobacterium abscessus Lung Infection: A French Observational Experience
por: Chiron, Raphael, et al.
Publicado: (2022)

Pulmonary Mycobacterium avium infection demonstrating unusual lobar caseous pneumonia
por: Okuzumi, Shinichi, et al.
Publicado: (2016)

Cutaneous Mycobacterium fortuitum Infection: Successfully Treated with Amikacin and Ofloxacin Combination
por: Sethi, Sunil, et al.
Publicado: (2014)

Amikacin exposure and susceptibility of macrolide-resistant Mycobacterium abscessus
por: Daniel-Wayman, Shelby, et al.
Publicado: (2019)

Consolidations in Nodular Bronchiectatic Mycobacterium Avium Complex Lung Disease: Mycobacterium Avium Complex or Other Infection?
por: Im, Soo Ah, et al.
Publicado: (2010)

Prosthetic joint infections caused by Mycobacterium avium complex: a series of five cases
por: Dobos, Katharine, et al.
Publicado: (2022)

Mannosylated Lipoarabinomannans from Mycobacterium Avium Subsp. Paratuberculosis Alters the Inflammatory Response by Bovine Macrophages and Suppresses Killing of Mycobacterium Avium Subsp. Avium Organisms
por: Souza, Cleverson, et al.
Publicado: (2013)

Overexpression of RORγt Enhances Pulmonary Inflammation after Infection with Mycobacterium Avium
por: Matsuyama, Masashi, et al.
Publicado: (2016)

1375. Laboratory Abnormalities Among Patients with Pulmonary Mycobacterium avium Complex Infections
por: Varley, Cara D, et al.
Publicado: (2019)

Tuberculosis in Birds: Insights into the Mycobacterium avium Infections
por: Dhama, Kuldeep, et al.
Publicado: (2011)

Mycobacterium avium subsp. hominissuis Infection in Horses
por: Kriz, Petr, et al.
Publicado: (2010)

Endobronchial Mycobacterium avium Infection in an Immunocompetent Patient
por: Kang, Seung-Hwa, et al.
Publicado: (2013)

An association between pulmonary Mycobacterium avium-intracellulare complex infections and biomarkers of Th2-type inflammation
por: Pfeffer, Paul E., et al.
Publicado: (2017)

The Effect of Mycobacterium avium Complex Infections on Routine Mycobacterium bovis Diagnostic Tests
por: Barry, Claire, et al.
Publicado: (2011)

The role of rifampicin within the treatment of Mycobacterium avium pulmonary disease
por: Schildkraut, Jodie A., et al.
Publicado: (2023)

A marmoset model for Mycobacterium avium complex pulmonary disease
por: Peters, Jay, et al.
Publicado: (2023)

Inducible Resistance to Amikacin in Mycobacterium abscessus Isolated in Beijing, China
por: Zhang, Zhijian, et al.
Publicado: (2022)

Genomic homogeneity between Mycobacterium avium subsp. avium and Mycobacterium avium subsp. paratuberculosis belies their divergent growth rates
por: Bannantine, John P, et al.
Publicado: (2003)

Prevalence and risk factors for chronic co-infection in pulmonary Mycobacterium avium complex disease
por: Fujita, Kohei, et al.
Publicado: (2014)

Pulmonary Mycobacterium avium Infection in a Patient with Crohn's Disease under Azathioprine Treatment
por: Hirano, Tomonori, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cu6q09cgdqmenvilklpk9vb9g8